Library of drug-like molecules

ImmuPharma owns the rights to a virtual library of heterocyclic urea molecules – 70 per cent of which are considered as drug-like based on their physiochemical characteristics. Commercially available libraries are generally considered to contain just 35-40 per cent drug-like molecules. 

ImmuPharma is using drug modelling and screening in-house in conjunction with CNRS and others to select and manufacture the molecules. Some 300,000 of these molecules may be able to be synthesized based on this core structure.